Clinical Trial

Protocol for Integrating Mass Drug Administration Into Primary Health Care in Western Kenya

Completed
View on ClinicalTrials.gov →
Summary
This study aims to determine whether distributing deworming drugs through routine healthcare services at the first point of contact in the health system is an effective way to prevent and treat worm infections in Western Kenya. This will be compared to the current campaign-based method that operates outside the health system. The main questions it aims to answer are: * Is the alternative method suitable and achievable in the targeted area? * What percentage of the population does this method cover? How does it compare with the current method? * How cost-effective is this alternative method? Researchers will compare outcomes in wards where the integrated method of drug administration is implemented (intervention arm) to wards where the standard campaign-based method is continued (control arm) to answer these questions. Participants from both arms of the study will: * Community members will respond to survey questions on their experience and access levels to deworming drugs. Some will also participate in Focus Group Discussions. * Health facility heads will be interviewed to assess the health facility and collect cost data. * Key stakeholders within the county administration will be engaged in key informant interviews. * Community Health Promoters will participate in Focus Group Discussions.
Trial Details
NCT Number NCT07507461
Lead Sponsor Amref Health Africa
Conditions Soil Transmitted Helminth (STH) Infections, Schistosomiasis Infection
Enrollment 1,229 participants
Start Date 2025-05-22
Primary Completion 2025-10-10 (estimated)
Study Completion 2025-10-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-02